Nearly 200 deaths linked to weight-loss drugs Ozempic and Mounjaro in the UK

The UK is grappling with the fallout from nearly 200 deaths linked to the weight-loss drugs Ozempic and Mounjaro. The deaths are linked to the drugs' use as a weight-loss aid. The UK's Medicines and Healthcare products Regulatory Agency is investigating the deaths. The agency has not yet specified how many of the deaths are suspected to be directly caused by the drugs. The agency has not yet specified how many of the deaths are suspected to be directly caused by the drugs. The deaths are linked to the drugs' use as a weight-loss aid.

The drugs are approved for use in treating type 2 diabetes. However, they have also been widely prescribed off-label for weight loss. The drugs are manufactured by Novo Nordisk and Eli Lilly. The drugs are part of a class of medications known as GLP-1 receptor agonists. The drugs work by mimicking natural hormones in the body to regulate appetite and blood sugar. The investigation comes amid growing concerns about the safety of these drugs.

The Times of India and Sky News have reported that hundreds of deaths have been suspected of being linked to the drugs. The Independent has reported that more than 150 deaths have been reported after the use of weight-loss drugs. The Times has reported that pancreatitis is a known risk associated with these drugs. The LADbible has reported that a grandmother died after increasing her dose of Mounjaro. The investigation is ongoing, and the regulator has not yet released a final report on the findings.